Sol-Gel Technologies Ltd. (SLGL) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Sol-Gel Technologies Ltd. (SLGL) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $215.6M, listed on NASDAQ, employing roughly 34 people, carrying a beta of 1.17 to the broader market. Sol-Gel Technologies Ltd. Led by Moshe Arkin, public since 2018-02-01.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for SLGL as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.